Biocapital: The Constitution of Postgenomic Life by Kaushik Sunder Rajan ( review). Article (PDF Available) in East Asian Science Technology and Society an. Article. Genomic Capital: Public Cultures and Market Logics of Corporate Biotechnology · Kaushik Sunder Rajan. Science as Culture. Volume 12, – Issue 1. Kaushik Sunder Rajan, Biocapital: The Constitution of. Postgenomic Life. Durham, NC: Duke University Press, pp.$, hardcover;.
|Published (Last):||24 December 2008|
|PDF File Size:||1.15 Mb|
|ePub File Size:||5.82 Mb|
|Price:||Free* [*Free Regsitration Required]|
Despite the obvious limitations of his terrain, being more than one step removed from the biotech startups and big pharma industries that are at the core of biocapital, biocalital author was able to conduct an interesting case study of corporate life that is presented in the last chapter of the book.
Amazon Advertising Find, attract, and engage customers. One of these items ships sooner than the other.
Sign up for Subject Matters email updates to receive discounts, new book announcements, and more. Biocapital is a major theoretical contribution to science studies and political economy. Biotechnology and Capitalism in the Neoliberal Era. As a result, the spirit of start-up capitalism is very different from the protestant ethic as described by Max Weber.
Biocapital: The Constitution of Postgenomic Life – Kaushik Sunder Rajan – Google Books
Purbasha Mazumdar rated it really liked it Sep 20, In a biotechnological utopia, with the DNA of the entire humanity mapped and sequenced, scientists and pharmaceutical companies can finally work together to provide highly customized diagnoses and cures for diseases and genetic defects. Learn more about Amazon Prime. Customers who bought this item also bought. English Choose a language for shopping.
Biocapital: The Constitution of Postgenomic Life by Kaushik Sunder Rajan
Leah rated it really liked it May 17, biiocapital In fact, many Indian companies tend to engage in production or research work on a contractual basis for western businesses. Daniel rated it really liked it Dec 25, Jun 03, Chris rated it it was amazing Shelves: Lists with This Book. In the process, he illuminates the global flow of ideas, information, capital, and people connected to biotech initiatives.
While corporations, universities, and governments rushed into this sector in recent decades, the genomics industry has been creating new dynamics as well as hegemonies as it becomes increasingly plugged rajna the global political economy.
Biocapital: The Constitution of Postgenomic Life
Purchase paper copies of MIT theses. This crap is boring AF. Liz rated it really liked it Feb 27, Project MUSE promotes the creation and dissemination of essential humanities and social science resources through collaboration with libraries, publishers, and scholars worldwide.
By far one of the best texts re-engaging Marx In this sense, Mr. Perhaps the most appealing section of Rajan’s research has been the skeptical treatment of the hyperpositive pronouncements and promises of industry players both linguistically and ideologically as mechanisms of articulating “genomic fetishism. This is where India comes as a useful counterpoint.
If you would like to authenticate using a different subscribed institution that supports Shibboleth authentication or have your own login and password to Project MUSE, click ‘Authenticate’. But as he recalls, “trying to get into the belly of the corporate beast” was a frustrating experience.
Some features of this site rajxn not work without it.
There is really nothing like the argument and synthesis Kaushik Sunder Rajan provides, which is surprising given how important his topic is. The methodology followed in this dissertation is multi-sited ethnography. Write a customer review. Open Preview See a Problem? Instead, he uses Marx as “a methodologist from whom one can learn to analyze rapidly emergent political economic and epistemic structures.
Hype and vision form the “discursive apparatus of biocapital”: Occasionally, Duke University Rajna controls the rights to maps or other drawings. He draws on his research with scientists, entrepreneurs, venture capitalists, and policymakers to compare drug development in the two countries, examining the practices and goals of research, the financing mechanisms, the relevant government regulations, and the hype and marketing surrounding promising new technologies.